Related Experiment Video
Updated: Apr 20, 2026

Author Spotlight: Advancements in Nanoparticle Technology for Drug Delivery and Immunotherapy
Published on: November 10, 2023
Quo vadis nanomedicine?
Robert Luxenhofer1, Matthias Barz, Michael Schillmeier
1Functional Polymer Materials, Chair for Chemical Technology of Materials Synthesis, Julius-Maximilians-University Würzburg, Röntgenring 11, 97070 Würzburg, Germany.
Abstract:
The interdisciplinary workshop 'Quo Vadis Nanomedicine?' was held on 10-11 April 2014 at the University of Exeter (Exeter, UK), coorganized by the Schumpeter-Research Group 'Innovations in Nanomedicine', funded by the VolkswagenStiftung at Exeter University, and the Sonderforschungsbereich (STB; collaborative research centre) 1066 'Nanodimensional Polymer Therapeutics for Tumor Therapy', funded by the German Research Council (DFG) at the Johannes Gutenberg-University (Mainz, Germany). This international workshop brought together scientists, philosophers and social scientists in order to reflect, discuss and rethink the practices, concepts, methods, models and metaphors, as well as the medical and regulatory needs in current nanomedical research and its possible futures.
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Site-Targeted Drug Delivery Systems: Polymeric Carriers

